3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Melanoma
3
Breast Neoplasms
3
Smoldering Multiple Myeloma
1
Psoriasis
1
Polycystic Ovary Syndrome
1
Osteoarthritis
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Liver Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
deucravacitinib
1
cabozantinib
1
Vitamin D
1
Standard of Care
1
Specimen Handling
1
Practice Guidelines as Topic
1
Platinum Compounds
1
Nivolumab
1
Methods
1
Ipilimumab
1
Interviews as Topic
1
Fish Oils
1
Fatty Acids, Omega-3
1
Exercise
1
Eicosapentaenoic Acid
1
Educational Status
1
Early Intervention, Educational
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Psoriasis
×
Docosahexaenoic Acids
×
1 year
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts